Shanghai Allist Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 114.70

Shanghai Allist Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 4.34% on July 13, 2026. The stock reached an intraday low of CNY 114.70, reflecting a challenging day in the market. Despite this downturn, the company has shown impressive performance over the longer term. Over the past month, Shanghai Allist Pharmaceuticals has surged by 41.61%, significantly outperforming the China Shanghai Composite, which declined by 2.92%. Year-to-date, the stock has gained 12.92%, while the broader index has seen a negative return of 1.39%. In terms of financial health, the company reported a robust operating cash flow of CNY 2,163.79 million and a net profit growth of 59.72% to CNY 1,187.76 million in the first half of the year. With a return on equity of 30.78% and a price-to-book ratio of 4.67, Shanghai Allist Pharmaceuticals maintains a strong market position within the pharmaceuticals and biotechnology sector.